惊厥性癫痫持续状态患者管理期间发生心脏骤停:特征、预测因素与结局
这项回顾性多中心研究纳入法国和比利时17个大学或其附属医院ICU收治的49例惊厥性癫痫持续状态合并心脏骤停患者,并与235例无心脏骤停的对照比较。病例组从医疗队到达至心脏骤停的中位时间为25分钟,首次记录心律为无收缩(25例,51%)和无脉电活动(13例,27%)。对照组1年良好结局(Glasgow结局量表评分5分)比例显著高于病例组(90/235,38% vs 10/49,21%;p=0.02)。多变量分析显示,现场血氧饱和度低于97%、早期管理期间并发症和药物中毒所致惊厥性癫痫持续状态是心脏骤停的独立预测因素,而合并至少一种心脏、呼吸或神经系统(除癫痫外)疾病预测不发生心脏骤停。
要点
- 惊厥性癫痫持续状态患者从医疗队到达至心脏骤停的中位时间为25分钟(四分位距5-85分钟)。
- 心脏骤停病例首次记录心律为无收缩占51%(25例),无脉电活动占27%(13例)。
- 对照组1年良好结局(Glasgow结局量表评分5分)比例为38%(90/235),显著高于病例组的21%(10/49;p=0.02)。
- 现场血氧饱和度低于97%(OR 2.66;95%CI 1.03-7.26;p=0.04)、早期管理并发症(OR 11.98;95%CI 4.67-34.69;p<0.0001)和药物中毒所致惊厥性癫痫持续状态(OR 4.13;95%CI 1.27-13.53;p=0.02)是心脏骤停的独立预测因素。
- 合并至少一种心脏、呼吸或神经系统(除癫痫外)疾病预测不发生心脏骤停(OR 0.28;95%CI 0.10-0.80;p=0.02)。
适用人群与场景
- 2000年至2015年间法国和比利时17个大学或大学附属医院ICU连续收治的、因惊厥性癫痫持续状态初始管理期间发生院外心脏骤停并成功复苏后入ICU管理的患者。
- 对照为单中心惊厥性癫痫持续状态患者注册中无心脏骤停的患者。
红旗征与不能漏的情况
- 现场血氧饱和度低于97%是心脏骤停的独立预测因素(OR 2.66;95%CI 1.03-7.26;p=0.04)。
- 早期管理期间发生并发症是心脏骤停的强独立预测因素(OR 11.98;95%CI 4.67-34.69;p<0.0001)。
- 药物中毒所致惊厥性癫痫持续状态是心脏骤停的独立预测因素(OR 4.13;95%CI 1.27-13.53;p=0.02)。
研究设计与关键结果
- 回顾性多中心研究,纳入49例惊厥性癫痫持续状态合并心脏骤停病例和235例对照。
- 病例组从医疗队到达至心脏骤停的中位时间为25分钟(四分位距5-85分钟)。
- 首次记录心律:无收缩25例(51%),无脉电活动13例(27%)。
- 1年良好结局(Glasgow结局量表评分5分):对照组90/235(38%)vs 病例组10/49(21%),p=0.02。
- 多变量分析独立预测因素:现场血氧饱和度低于97%(OR 2.66;95%CI 1.03-7.26;p=0.04)、药物中毒所致惊厥性癫痫持续状态(OR 4.13;95%CI 1.27-13.53;p=0.02)、早期管理期间并发症(OR 11.98;95%CI 4.67-34.69;p<0.0001);合并至少一种心脏、呼吸或神经系统(除癫痫外)疾病预测不发生心脏骤停(OR 0.28;95%CI 0.10-0.80;p=0.02)。
证据类型、等级与局限
- 证据类型:回顾性多中心研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,相对低氧血症、现场管理并发症和药物中毒所致惊厥性癫痫持续状态是心脏骤停的强早期预测因素,提示有改进空间。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Cardiac arrest is a catastrophic event that may arise during the management of convulsive status epilepticus. We aimed to report the clinical characteristics, outcomes, and early predictors of convulsive status epilepticus-related cardiac arrest.
DESIGN: Retrospective multicenter study.
SETTING: Seventeen university or university affiliated participating ICUs in France and Belgium.
PATIENTS: Consecutive patients admitted to the participating ICUs for management of successfully resuscitated out-of-hospital cardiac arrest complicating the initial management of convulsive status epilepticus between 2000 and 2015. Patients were compared with controls without cardiac arrest identified in a single-center registry of convulsive status epilepticus patients, regarding characteristics, management, and outcome.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We included 49 cases with convulsive status epilepticus-cardiac arrest and 235 controls. In the cases, median time from medical team arrival to cardiac arrest was 25 minutes (interquartile range, 5-85 min). First recorded rhythm was asystole in 25 patients (51%) and pulseless electrical activity in 13 patients (27%). A significantly larger proportion of patients had a favorable 1-year outcome (Glasgow Outcome Scale score of 5) among controls (90/235; 38%) than among cases (10/49; 21%; p = 0.02). By multivariate analysis, independent predictors of cardiac arrest were pulse oximetry less than 97% on scene (odds ratio, 2.66; 95% CI, 1.03-7.26; p = 0.04), drug poisoning as the cause of convulsive status epilepticus (odds ratio, 4.13; 95% CI, 1.27-13.53; p = 0.02), and complications during early management (odds ratio, 11.98; 95% CI, 4.67-34.69; p < 0.0001). Having at least one comorbidity among cardiac, respiratory, and neurologic (other than epilepsy) conditions predicted absence of cardiac arrest (odds ratio, 0.28; 95% CI, 0.10-0.80; p = 0.02).
CONCLUSIONS: In patients managed for convulsive status epilepticus, relative hypoxemia, on-scene management complications, and drug poisoning as the cause of convulsive status epilepticus were strong early predictors of cardiac arrest, suggesting areas for improvement.
参考来源
- Legriel S, Bresson E, Deye N, et al. Cardiac Arrest in Patients Managed for Convulsive Status Epilepticus: Characteristics, Predictors, and Outcome. Crit Care Med. 2018. PMID: 29742585. doi:10.1097/CCM.0000000000003196
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。